Elan (ELN) Higher On Reports of Novartis Talks
More News related to ELN
- El Nino Closes $1.5 Million Non-Brokered Private Placement; Update on the Kasala Copper Project in the DRC
- The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments
- Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
- Elan Corporation Plc Announces Expiration of Tender Offer for 73/4% Senior Fixed Rate Notes Due 2011
- UBS Downgrades Elan (ELN) to Neutral
More News related to NVS
- Despite Novartis Denial, UBS Makes A Strong Case That They Should Buy Alcon (ACL)
- Novartis (NVS) has no plans to buy out Alcon (ACL) minority shares - Bloomberg
- Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
- Vanda Pharma (VNDA) to Receive $200M from Novartis (NVS) Upon Expiration of HSR Antitrust Improvements Act
- FDA Approves Agriflu Seasonal Influenza Vaccine
More News related to Mergers and Acquisitions
- Biogen (BIIB) Boosts Bid for Facet Biotech (FACT) to $17.50/Share in Cash
- Service Corporation (SCI) Acquires Palm Mortuaries
- PG&E (PCG) to Purchase, Operate Major Wind Generating Plant in SoCal
- Cree (CREE) Acquires SiC Patent Portfolio from Daimler AG
- Denbury Resources (DNR) Enters into $430.7M Stock and Cash Conroe Field Acquisition
Shares of Elan (NYSE: ELN) are higher in overseas trading following reports in the Sunday Times, Novartis (NYSE: NVS) is in talks to buy part of the Dublin, Ireland-based drugmaker.
Spokespersons from both companies declined to comment on the speculation.
The Sunday Times cited a "well-placed source" which said a decision is "some way off."
Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
Mergers and AcquisitionsMomentum Movers
Rumors
Stocks Mentioned
-0.09
+0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
